I am a
Home I AM A Search Login

Papers of the Week


Papers: 13 Jul 2019 - 19 Jul 2019


Human Studies, Pharmacology/Drug Development

PAIN TYPE:
Migraine/Headache


2019 Jul 15


J Headache Pain


20


1

Real-world effectiveness of onabotulinumtoxinA treatment for the prevention of headaches in adults with chronic migraine in Australia: a retrospective study.

Authors

Stark C, Stark R, Limberg N, Rodrigues J, Cordato D, Schwartz R, Jukic R
J Headache Pain. 2019 Jul 15; 20(1):81.
PMID: 31307383.

Abstract

OnabotulinumtoxinA (BOTOX®, Allergan plc, Dublin, Ireland) is approved for the preventive treatment of headaches in adult patients with chronic migraine (CM) in Australia by the country's reimbursement mechanism for medicines, the Pharmaceutical Benefits Scheme (PBS). To our knowledge, this study represents the first focused report evaluating real-world evidence of onabotulinumtoxinA treatment via the PBS in Australian clinics.